Detection of donor-specific anti-HLA antibodies with flow cytometry in eluates and sera from renal transplant recipients with chronic allograft nephropathy

被引:103
作者
Martin, L
Guignier, F
Mousson, C
Rageot, D
Justrabo, E
Rifle, G
机构
[1] Sch Med, Dept Pathol, Dijon, France
[2] Etab Francais Sang Bourgogne, Tissue Typing Lab, Dijon, France
[3] Univ Hosp, Dept Nephrol Intens Care & Transplantat, Dijon, France
[4] Sch Med, Lab Immunomanipulat Allo & Autoreact, UPRES EA 563, Dijon, France
关键词
D O I
10.1097/01.TP.0000078895.24606.45
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Chronic allograft nephropathy (CAN), which remains the main cause of graft loss after kidney transplantation, is still poorly understood. Because anti-HILA antibodies may be involved in the pathogenesis of CAN, this study was performed to look for donor-specific antibodies (DSA) fixed onto renal transplants with CAN. Methods. DSA were identified after elution with flow cytometric assay and/or flow cytometric crossmatches in 20 transplants removed after irreversible graft failure caused by CAN and in control samples from 2 transplants with relapsing glomerulopathy, 2 transplants lost after vascular thrombosis, and 4 normal kidneys. The results were compared with those obtained in the serum samples 1 year after grafting, at the time of transplantectomy, and within 2 months after transplantectomy. Results. IgG anti-class 1, anti-class 11, or both DSA were identified in 70.6% of eluates versus 73.6% of posttransplantectomy serum samples (NS), 42.1% of 1-year postgrafting serum samples (P<0.05), and 31.6% of serum samples at the time of transplantectomy (P<0.05). Our data show a good correlation between the target of anti-HLA antibodies found in both eluates and posttransplantectomy serum samples, but the precise specificity of anti-HLA antibodies is more often assigned in posttransplantectomy serum samples than in eluates. This problem needs further evaluation. Conclusion. This study shows that testing for anti-HIA DSA in eluates from removed kidney transplants using flow cytometry can be achieved and is highly efficient. It already suggests that both anti-class I and anti-class 11 IIIA antibodies can be involved in CAN. Further studies are now needed to evaluate the possibility of identifying such antibodies in the eluates of transplant biopsy specimens from recipients experiencing CAN.
引用
收藏
页码:395 / 400
页数:6
相关论文
共 23 条
[1]   Postoperative production of anti-donor antibody and chronic rejection in renal transplantation [J].
Abe, M ;
Kawai, T ;
Futatsuyama, K ;
Tanabe, K ;
Fuchinoue, S ;
Teraoka, S ;
Toma, H ;
Ota, K .
TRANSPLANTATION, 1997, 63 (11) :1616-1619
[2]   Antibodies to vascular endothelial cells in chronic rejection of renal allografts [J].
Ball, B ;
Mousson, C ;
Ratignier, C ;
Guignier, F ;
Glotz, D ;
Rifle, G .
TRANSPLANTATION PROCEEDINGS, 2000, 32 (02) :353-354
[3]  
Brando B, 1996, EUR J HISTOCHEM, V40, P53
[4]  
BRAY RA, 1994, METHOD CELL BIOL, V41, P103
[5]  
Christiaans MHL, 2000, TRANSPLANTATION, V69, P917
[6]  
CRAMER DV, 1998, TRANSPLANT REV, V12, P166
[7]  
Fellström B, 2001, TRANSPLANTATION, V71, pSS10
[8]   Anti-cell surface endothelial antibodies in sera from cardiac and kidney transplant recipients: Association with chronic rejection [J].
Ferry, BL ;
Welsh, KI ;
Dunn, MJ ;
Law, D ;
Proctor, J ;
Chapel, H ;
Yacoub, MH ;
Rose, ML .
TRANSPLANT IMMUNOLOGY, 1997, 5 (01) :17-24
[9]   THE SIGNIFICANCE OF THE ANTI-CLASS-I ANTIBODY-RESPONSE .1. CLINICAL AND PATHOLOGICAL FEATURES OF ANTI-CLASS I-MEDIATED REJECTION [J].
HALLORAN, PF ;
WADGYMAR, A ;
RITCHIE, S ;
FALK, J ;
SOLEZ, K ;
SRINIVASA, NS .
TRANSPLANTATION, 1990, 49 (01) :85-91
[10]   POSTTRANSPLANT ANTIDONOR LYMPHOCYTOTOXIC ANTIBODY-PRODUCTION IN RELATION TO GRAFT OUTCOME [J].
MARTIN, S ;
DYER, PA ;
MALLICK, NP ;
GOKAL, R ;
HARRIS, R ;
JOHNSON, RWG .
TRANSPLANTATION, 1987, 44 (01) :50-53